« Back to Record
Citation APA

Loi, S., Sirtaine, N., Piette, F., Salgado, R., Viale, G., Van Eenoo, F., Rouas, G., Francis, P., Crown, J. P. A., Hitre, E., de Azambuja, E., Quinaux, E., Di Leo, A., Michiels, S., Piccart-Gebhart, M., & Sotiriou, C. (2013). Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. Journal of clinical oncology, 31(7), 860-867. doi:10.1200/JCO.2011.41.0902


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/146365

Loi, S., Sirtaine, N., Piette, F., Salgado, R., Viale, G., Van Eenoo, F., Rouas, G., Francis, P., Crown, J. P. A., Hitre, E., de Azambuja, E., Quinaux, E., Di Leo, A., Michiels, S., Piccart-Gebhart, M., & Sotiriou, C. (2013). Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98. Journal of clinical oncology, 31(7), 860-867. doi:10.1200/JCO.2011.41.0902